Why invest in AMS

We are a leading developer and manufacturer of advanced products for the global surgical and wound care markets.  We can offer:

Share performance and key events over the last 10 years

We have an outstanding historical track record:

• Strong presence in US and EU markets
• Reinforced partnerships with large healthcare companies
• Investment in direct sales force in core markets
• Selective acquisitions successfully integrated in the Group
• Sales and EBITDA 5 year CAGR of 21% and 30% respectively
• Well positioned customer oriented product portfolio
• Constant investment in R&D
• Strong share price performance

…..and a clear strategy

• Continued expansion in the US and newer territories
• Move towards more value added partnerships
• Development of specialised sales teams to serve new segments
• Explore opportunities for synergistic acquisitions
• Leverage existing platform and seek further operational efficiencies
• Extend product range
• Attractive pipe-line of new products
• Clear mandate from investors to pursue growth

The Corporate Growth Strategy can be outlined as follows: